| Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects O Čulić, V Eraković, I Čepelak, K Barišić, K Brajša, Ž Ferenčić, R Galović, ... European journal of pharmacology 450 (3), 277-289, 2002 | 342 | 2002 |
| Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin M Bosnar, Z Kelneric, V Munic, V Erakovic, MJ Parnham Antimicrobial agents and chemotherapy 49 (6), 2372-2377, 2005 | 218 | 2005 |
| Obesity II: establishing causal links between chemical exposures and obesity JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ... Biochemical pharmacology 199, 115015, 2022 | 159 | 2022 |
| Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment MJ Parnham, O Čulić, V Eraković, V Munić, S Popović-Grle, K Barišić, ... European journal of pharmacology 517 (1-2), 132-143, 2005 | 141 | 2005 |
| Azithromycin distinctively modulates classical activation of human monocytes in vitro M Vrančić, M Banjanac, K Nujić, M Bosnar, T Murati, V Munić, ... British journal of pharmacology 165 (5), 1348-1360, 2012 | 126 | 2012 |
| Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A. 1 cells M Banjanac, VM Kos, K Nujić, M Vrančić, D Belamarić, S Crnković, ... Pharmacological research 66 (4), 357-362, 2012 | 89 | 2012 |
| Cloning and molecular characterization of apical efflux transporters (ABCB1, ABCB11 and ABCC2) in rainbow trout (Oncorhynchus mykiss) hepatocytes R Zaja, V Munić, RS Klobučar, A Ambriović-Ristov, T Smital Aquatic toxicology 90 (4), 322-332, 2008 | 79 | 2008 |
| Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype K Nujić, M Banjanac, V Munić, D Polančec, VE Haber Cellular immunology 279 (1), 78-86, 2012 | 76 | 2012 |
| Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs)–A comparison with lysosomotropic drugs DS Garcia, M Sjödin, M Hellstrandh, U Norinder, V Nikiforova, J Lindberg, ... Chemico-biological interactions 281, 1-10, 2018 | 73 | 2018 |
| Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays V Munić, Ž Kelnerić, L Mikac, VE Haber European journal of pharmaceutical sciences 41 (1), 86-95, 2010 | 68 | 2010 |
| Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties DS Polančec, V Munić Kos, M Banjanac, M Vrančić, S Čužić, D Belamarić, ... Journal of leukocyte biology 91 (2), 229-243, 2012 | 60 | 2012 |
| Modeling cellular pharmacokinetics of 14-and 15-membered macrolides with physicochemical properties V Stepanić, S Koštrun, I Malnar, M Hlevnjak, K Butkovic, I Caleta, ... Journal of medicinal chemistry 54 (3), 719-733, 2011 | 59 | 2011 |
| The GOLIATH project: Towards an internationally harmonised approach for testing metabolism disrupting compounds J Legler, D Zalko, F Jourdan, M Jacobs, B Fromenty, P Balaguer, ... International Journal of Molecular Sciences 21 (10), 3480, 2020 | 50 | 2020 |
| Intensity of macrolide anti-inflammatory activity in J774A. 1 cells positively correlates with cellular accumulation and phospholipidosis V Munić, M Banjanac, S Koštrun, K Nujić, M Bosnar, N Marjanović, J Ralić, ... Pharmacological research 64 (3), 298-307, 2011 | 50 | 2011 |
| Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19 U Norinder, A Tuck, K Norgren, VM Kos Biomedicine & Pharmacotherapy 130, 110582, 2020 | 44 | 2020 |
| Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin M Matijašić, VM Kos, K Nujić, S Čužić, J Padovan, G Kragol, S Alihodžić, ... Pharmacological research 66 (4), 332-342, 2012 | 35 | 2012 |
| Obesity III: Obesogen assays: Limitations, strengths, and new directions CD Kassotis, FS Vom Saal, PJ Babin, D Lagadic-Gossmann, H Le Mentec, ... Biochemical pharmacology 199, 115014, 2022 | 30 | 2022 |
| Characterization of rhodamine-123, calcein and 5 (6)-carboxy-2′, 7′-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells V Munić, M Hlevnjak, VE Haber European journal of pharmaceutical sciences 43 (5), 359-369, 2011 | 23 | 2011 |
| Cloning and mRNA expression analysis of an ABCG2 (BCRP) efflux transporter in rainbow trout (Oncorhynchus mykiss) liver and primary hepatocytes R Žaja, V Munić, T Smital Marine environmental research 66 (1), 77-79, 2008 | 20 | 2008 |
| From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures L Birgersson, G Borbély, N Caporale, PL Germain, M Leemans, F Rendel, ... bioRxiv, 206664, 2017 | 17 | 2017 |
